Lv4
448 积分 2023-11-06 加入
BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy
2天前
已完结
Natural killer cell therapies
7天前
已完结
A tetraspecific engager armed with a non-alpha IL-2 variant harnesses natural killer cells against B cell non-Hodgkin lymphoma
7天前
已完结
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
15天前
已完结
Study of the dynamic changes in the non-volatile chemical constituents of black tea during fermentation processing by a non-targeted metabolomics approach
15天前
已完结
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis
15天前
已完结
Managing hypogammaglobulinemia in patients treated with CAR-T-cell therapy: key points for clinicians
15天前
已完结
Bispecific T cell engager therapy for refractory rheumatoid arthritis
19天前
已完结
Model‐Informed Drug Development of the Masked Anti‑PD‑L1 Antibody CX‐072
29天前
已完结
First-in-Human Study of the Biodistribution and Pharmacokinetics of 89Zr-CX-072, a Novel Immunopet Tracer Based on an Anti–PD-L1 Probody
29天前
已完结
皖公网安备34019202002308
